Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases [8]

Rheumatology

Volumn 46, Issue 6, 2007, Pages 1042-1043

  Botsios, C ^a   Sfriso, Paolo ^a   Ostuni, P A ^a   Todesco, S ^a   Punzi, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; PREDNISOLONE ACETATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; CASE REPORT; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; IRIDOCYCLITIS; LETTER; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; TREATMENT DURATION; VISUAL ACUITY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MIDDLE AGED; SCLERITIS; TREATMENT OUTCOME;

EID: 34447303047     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem052     Document Type: Letter

References (10)

1. Okhravi N, Odufuwa B, McCluskey P, Lightman S. Scleritis. Surv Ophthalmol 2005;50:351-63.
2. Dick AD, Duncan L, Hale G, Waldmann H, Isaacs J. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. J Autoimmunity 1998;11;255-64.
3. Wakefield D, Lloyd A. The role of cytokines in the pathogenesis of inflammatory eye disease. Cytokine 1992;4:1-5.
4. Lim WK, Fujimoto C, Ursea R et al. Suppression of immune-mediated ocular inflammation in mice by interleukin 1 receptor antagonist administration. Arch Ophthalmol 2005;123:957-63.
5. Smith JR, Levinson RD, Holland GN et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 2001;45:252-7.
6. Lindstedt EW, Baarsma GS, Kuijpers RW, van Hagen PM. Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol 2005;89:533-6.
7. Taban M, Dupps WJ, Mandell B, Perez VL. Etanercept (Enbrel)-associated inflammatory eye disease: Case report and review of the literature. Ocul Immunol Inflamm 2006;14:145-50.
8. Dinarello CA. The many worlds of reducing interleukin-1. Arthritis Rheum 2005;52:1960-7.
9. Fitzgerald AA, Leclercq SA, Yan A, Hornik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 2005;52:1794-803.
10. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005;201:1479-86.